Download U6 RNAi Entry Vector (BLOCKiT)
Transcript
Troubleshooting, continued Ligation and Transformation Reactions, continued Problem Few kanamycinresistant colonies obtained on the selective plate, continued Many clones contain inserts with sequence mutations Poor sequencing results No colonies obtained on the selective plate Reason Solution Not enough transformation mixture plated Increase the amount of the transformation mixture plated. Selective plates contained too much kanamycin Use LB agar plates containing 50 µg/ml kanamycin for selection. Did not use the competent cells supplied with the kit Use the One Shot® TOP10 Chemically Competent E. coli supplied with the kit; transformation efficiency is > 1 x 109 cfu/µg DNA. Not enough of the ligation reaction transformed Increase the amount of ligation reaction transformed. Did not perform the 1 hour grow-out period before plating the transformation mixture After the heat-shock step, add S.O.C. Medium and incubate the bacterial culture for 1 hour at 37°C with shaking before plating. Poor quality single-stranded oligos used • Oligo preparation contains mutated sequences • Use mass spectrometry to check for peaks of the wrong mass. • Oligo preparation contains contaminants • Order HPLC or polyacrylamide gel (PAGE)-purified oligos. • Order oligos from Invitrogen’s custom primer synthesis service (see our Web site for more information). Did not use the competent cells supplied with the kit Use the One Shot® TOP10 Chemically Competent E. coli supplied with the kit; transformation efficiency is > 1 x 109 cfu/µg DNA. Loss of sequencing signal in the hairpin region due to secondary structure formation • Use high-quality, purified plasmid DNA for sequencing. • Add DMSO to the sequencing reaction to a final concentration of 5%. • Increase the amount of template used for sequencing (up to twice the normal amount). • Use a 7:1 molar ratio of dITP:dGTP in your sequencing reaction. Used the wrong antibiotic for selection Select for transformants on LB agar plates containing 50 µg/ml kanamycin. continued on next page 32